MBMBIO - Key Persons
Job Titles:
- Vice President of Business Operations and Co - Founder of MBM
- VP of Operations, Co - Founder
Bio
Ariel Wu is the Vice President of Business Operations and Co-Founder of MBM. She is responsible for managing MBM's operational activities, including finance, administration, personnel, and legal affairs. She has more than 20 years pharmaceutical industry experience with tenures in companies such as Johnson & Johnson, Roche and GlaxoSmithKline, taking on varied roles including product management, sales & marketing and business development. She managed and launched several blockbuster products in oncology and antiviral fields and was awarded GSK Asia Pacific President Award for outstanding performance.
Job Titles:
- Professor of Cancer Medicine at the University of Oxford
Professor David Kerr is a professor of cancer medicine at the University of Oxford in Oxford, England. He is recognized internationally for his work in the research and treatment of colorectal cancer, and has published more than 400 papers. His clinical research into adjuvant therapy of early stage colorectal cancer has contributed to saving thousands of lives over the past four decades. He has founded three university spin-out companies: COBRA Therapeutics, Celleron Therapeutics, and Oxford Cancer Biomarkers. In 2002, he was appointed Commander of the British Empire by Queen Elizabeth and in 2010 was elected president of the European Society for Medical Oncology.x
Dr. John Maddison is a director in Room4 and has over 20 years of diverse commercial experience in the development, architecture design and management of artificial intelligence and machine learning projects. He is currently involved in leading multiple machine and deep learning A.I. projects with applications for automatic cell classification, IHC scoring, cell and tissue identification. He has filed 20+ international patents in the area of image processing using A.I. He is a member of the Institution of Engineering and Technology, a Chartered Engineer and a member of the Chartered Management Institute. He obtained his Ph.D. in electronic and information engineering from the University of Huddersfield and MBA from the University of Liverpool.
Job Titles:
- Chief Executive Officer
- Founder
- Chief Executive Officer and Founder of MBM
Bio
I Jackson Zhu, MD, MBA, is the Chief Executive Officer and Founder of MBM, where he leads an integrated team of business, medical and scientific experts in building the company's commercialization platform capabilities. He has worked in the pharmaceutical industry for more than 20 years, and has rich experience in a wide spectrum of roles including corporate strategy, M&A, business development and operations. Previously, he was the Greater China General Manager of Catalent, the world's largest R&D and advanced drug delivery technology solution provider. He was also a VP and Europe Regional Business Head of Boehringer Ingelheim, focused on operations and business strategy. He was elected as a Global Director of Precision Medicine as part of the World Economic Forum.
Bio
Lyon Chen, PhD, is the Chief Scientific Officer and one of the co-inventors of MBM's red blood cell liquid biopsy platform and is leading the research team in developing the technology for early cancer screening. He is also a principal investigator at Nanjing University where his research focus is on computational biology, genomics, and epigenetics. Previously, he was a senior strategy manager in GenScript Biotech Corporation, helping to establish the company's gene editing and bispecific antibody platform. He graduated with a PhD in molecular biology from University of Southern California.
Job Titles:
- Sales & Marketing Director
Job Titles:
- Vice President of Sales and Marketing
- VP of Sales & Marketing, Partner
Bio
Pang Liping is the Vice President of Sales and Marketing Operations and is responsible for leading a rapidly growing sales and marketing unit within MBM. He has more than 20 years experience in pharmaceutical and diagnostics sales & marketing, working for companies such as CSPC Pharmaceutical Group, BGI Genomics and Ebien Biotech. His successes include launching and growing a new cancer screening service that became the top-selling product in China, and managing a pharmaceutical sales department with over ¥2B in annual sales.
Job Titles:
- Regulatory Affairs and Quality Management Director
Shelly Sun is the Regulatory Affairs and Quality Management Director, and is responsible for MBM's product registration and production QC system. Previously, she worked in a similar capacity at Beijing Health Guard Biotechnology and Walvax Biotechnology and was responsible for the clinical trials and product registration and industrial manufacturing QC of two HPV vaccine products. She was a bioengineering graduate of Jiangsu Ocean University.
Job Titles:
- Medical Affairs Director
- Medical Department Director
Bio
Vivian Mao, MSc, is the Medical Department Director, and is leading MBM's multi-center clinical research collaborations and medical KOL engagement. Previously, she was a medical marketing manager at Jilin Yatai Pharmaceutical and Shanghai Sai'an Biomedical Technology, where she gained extensive experience in national multi-center clinical studies, product marketing strategy in both tumor drug development and in vitro diagnostic. She has a master's degree in genetics from Northeast Normal University. x
Job Titles:
- Boler Biotech Consulting
- Managing Partner at Boler Biotech Consulting
Bio
Mr. William Johnson is a managing partner at Boler Biotech Consulting. He is a partner and advisor to several company leaders and boards, and venture or industry-backed investment groups. He provides business expertise in sourcing, investigating and assessing scientific and market potential of new technologies, therapies and companies, developing and negotiating contracts for industry-academic partnerships, as well as helping his clients start up and guide transactional and project finances of early-stage portfolio ventures. He has a broad-based scientific background and earlier worked for organizations including Novartis, Wyeth, EMD Millipore, Broad Institute and Mayo Clinic.